Abstract
We have recently demonstrated that in an autosomal dominant porphyria, erythropoietic protoporphyria (EPP), the coinheritance of a ferrochelatase (FECH) gene defect and of a wild-type low-expressed FECH allele is generally involved in the clinical expression of EPP. This mechanism may provide a model for phenotype modulation by minor variations in the expression of the wild-type allele in the other three autosomal dominant porphyrias that exhibit incomplete penetrance: acute intermittent porphyria (AIP), variegata porphyria (VP) and hereditary coproporphyria (HC), which are caused by partial deficiencies of hydroxy-methyl bilane synthase (HMBS), protoporphyrinogen oxidase (PPOX) and coproporphyrinogen oxidase (CPO), respectively. Given the dominant mode of inheritance of EPP, VP, AIP and HC, we first confirmed that the 200 overtly porphyric subjects (55 EPP, 58 AIP, 56 VP; 31 HC) presented a single mutation restricted to one allele (20 novel mutations and 162 known mutations). We then analysed the available single-nucleotide polymorphisms (SNPs) present at high frequencies in the general population and spreading throughout the FECH, HMBS, PPOX and the CPO genes in four case-control association studies. Finally, we explored the functional consequences of polymorphisms on the abundance of wild-type RNA, and used relative allelic mRNA determinations to find out whether low-expressed HMBS, PPOX and the CPO alleles occur in the general population. We confirm that the wild-type low-expressed allele phenomenon is usually operative in the mechanism of variable penetrance in EPP, but conclude that this is not the case in AIP and VP. For HC, the CPO mRNA determinations strongly suggest that normal CPO alleles with low-expression are present, but whether this low-expression of the wild-type allele could modulate the penetrance of a CPO gene defect in HC families remains to be ascertained.
Similar content being viewed by others
References
Alloisio N, Morle L, Maréchal J, Roux AF, Ducluzeau MT, Guetarni D, Pothier B (1991) Spαv/41: a common spectrin polymorphism at the αIV-αV domain junction. Relevance to the expression level of hereditary elliptocytosis due to α-spectrin variants located in trans. J Clin Invest 87:2169–2177
Anderson KE, Sassa S, Bishop DF, Desnick RJ (2001) The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 8th edn, vol 1. McGraw-Hill, New York, pp 2991–3062
Astrin KH, Desnick RJ (1994) Molecular basis of acute intermittent porphyria: mutations and polymorphisms in the human hydroxymethylbilane synthase gene. Hum Mutat 4:243–252
Borrego S, Saez ME, Ruiz A, Gimm O, Lopez-Alonso M, Antinolo G, Eng C (1999) Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression. J Med Genet 36:771–774
Brett D, Pospisil H, Valcarcel J, Reich J, Bork P (2002) Alternative splicing and genome complexity. Nat Genet 30:29–30
den Dunnen JT, Antonarakis SE (2001) Nomenclature for the description of human sequence variations. Hum Genet 109:121–124
Donnelly JG, Detombe S, Hindmarsh JT (2002) Single-strand conformational polymorphism and denaturing gradient gel electrophoresis in screening for variegate porphyria: identification of two new mutations. Ann Clin Lab Sci 32:107–113
Gouya L, Deybach JC, Lamoril J, Da Silva V, Beaumont C, Grandchamp B, Nordmann Y (1996) Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele. Am J Hum Genet 58:292–299
Gouya L, Puy H, Lamoril J, Da Silva V, Grandchamp B, Nordmann Y, Deybach JC (1999) Inheritance in erythropoietic protoporphyria: a common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation. Blood 93:2105–2110
Gouya L, Puy H, Robréau AM, Bourgeois M, Lamoril J, Da Silva V, Grandchamp B, Deybach JC (2002) The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wild-type FECH. Nat Genet 30:27–28
Gregor A, Schneider-Yin X, Szlendak U, Wettstein A, Lipniacka A, Rufenacht UB, Minder EI (2002) Molecular study of the hydroxymethylbilane synthase gene (HMBS) among Polish patients with acute intermittent porphyria. Hum Mutat 19:310
Martasek P, Nordmann Y, Grandchamp B (1994) Homozygous hereditary coproporphyria caused by an arginine to tryptophan substitution in coproporphyrinogen oxidase and common intragenic polymorphisms. Hum Mol Genet 3:477–480
Povey S, Lovering R, Bruford E, Wright M, Lush M, Wain H (2001) The HUGO Gene Nomenclature Committee (HGNC). Hum Genet 109:678–680
Puy H, Robréau AM, Rosipal R, Nordmann Y, Deybach JC (1996) Protoporphyrinogen oxidase : complete genomic sequence and polymorphisms in the human gene. Biochem Biophys Res Commun 226:226–230
Puy H, Deybach JC, Lamoril J, Robréau AM, Da Silva V, Gouya L, Grandchamp B, Nordmann Y (1997) Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria. Am J Hum Genet 60:1373–1383
Rosipal R, Lamoril J, Puy H, Da Silva V, Gouya L, De Rooij FW, Te Velde K, Nordmann Y, Martasek P, Deybach JC (1999) Systematic analysis of coproporphyrinogen oxidase gene defects in hereditary coproporphyria and mutation update. Hum Mutat 13:44–53
Rüfenacht UB, Gouya L, Schneider-Yin X, Puy H, Schäfer BW, Aquaron R, Nordmann Y, Minder EI, Deybach JC (1998) Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria. Am J Hum Genet 62:1341–1352
Sassa S, Kappas A (2000) Molecular aspects of the inherited porphyrias. J Intern Med 247:169–178
Whatley SD, Puy H, Morgan RR, Robréau AM, Roberts AG, Nordmann Y, Elder GH, Deybach JC (1999) Variegate porphyria in Western Europe: identification of PPOX gene mutations in 104 families, extent of allelic heterogeneity, and absence of correlation between phenotype and type of mutation. Am J Hum Genet 65:984–994
Wilmotte R, Marechal J, Morle L, Baklouti F, Philippe N, Kastally R, Kotula L, Delaunay J, Alloisio N (1993) Low expression allele αlely of red cell spectrin is associated with mutations in exon 40 (αv/41 polymorphism) and intron 45 and with partial skipping of exon 46. J Clin Invest 91:2091–2096
Wiman A, Floderus Y, Harper P (2002) Two novel mutations and coexistence of the 991C>T and the 1339C>T mutation on a single allele in the coproporphyrinogen oxidase gene in Swedish patients with hereditary coproporphyria. J Hum Genet 47:407–412
Yan H, Dobbie Z, Gruber SB, Markowitz S, Romans K, Giardiello FM, Kinzler KW, Vogelstein B (2002) Small changes in expression affect predisposition to tumorigenesis. Nat Genet 30:25–26
Yasui Y, Muranaka S, Tahara T, Shimizu R, Watanabe S, Horie Y, Nanba E, Uezato H, Takamiyagi A, Taketani S, Akagi R (2002) A new ferrochelatase mutation combined with low expression alleles in a Japanese patient with erythropoietic protoporphyria. Clin Sci 102:501-506
Yoo HW, Warner CA, Chen CH, Desnick RJ (1993) Hydroxymethylbilane synthase: complete genomic sequence and amplifiable polymorphisms in the human gene. Genomics 15:21–29
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gouya, L., Puy, H., Robreau, AM. et al. Modulation of penetrance by the wild-type allele in dominantly inherited erythropoietic protoporphyria and acute hepatic porphyrias. Hum Genet 114, 256–262 (2004). https://doi.org/10.1007/s00439-003-1059-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-003-1059-5